These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8165858)

  • 1. Purification and characterization of simian immunodeficiency virus (SIVmac) envelope glycoprotein gp130 from virus-infected cells.
    Jones DH; McBride BW; Roff MA; Maloney V; Farrar GH
    Vaccine; 1994; 12(3):250-8. PubMed ID: 8165858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130.
    Voss G; Dittmer U; Coulibaly C; Makoschey B; Petry H; Lüke W; Hunsmann G
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1757-63. PubMed ID: 8376957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of simian immunodeficiency virus, SIVMAC251, and of its external envelope glycoprotein, gp148.
    Gilljam G; Siridewa K; Hammar L
    J Chromatogr A; 1994 Jul; 675(1-2):89-100. PubMed ID: 8081461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and immunological characterization of SIV envelope glycoprotein produced in genetically engineered mammalian cells.
    Planelles V; Haigwood NL; Marthas ML; Mann KA; Scandella C; Lidster WD; Shuster JR; Van Kuyk R; Marx PA; Gardner MB
    AIDS Res Hum Retroviruses; 1991 Nov; 7(11):889-98. PubMed ID: 1760229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
    Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, purification, and characterization of recombinant HIV gp140. The gp41 ectodomain of HIV or simian immunodeficiency virus is sufficient to maintain the retroviral envelope glycoprotein as a trimer.
    Zhang CW; Chishti Y; Hussey RE; Reinherz EL
    J Biol Chem; 2001 Oct; 276(43):39577-85. PubMed ID: 11514580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
    Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
    J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation.
    Torres JV; Malley A; Banapour B; Anderson DE; Axthelm MK; Gardner MB; Benjamini E
    AIDS Res Hum Retroviruses; 1993 May; 9(5):423-30. PubMed ID: 7686386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus.
    Ahmad S; Lohman B; Marthas M; Giavedoni L; el-Amad Z; Haigwood NL; Scandella CJ; Gardner MB; Luciw PA; Yilma T
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):195-204. PubMed ID: 8198872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression, purification, and characterization of gp160e, the soluble, trimeric ectodomain of the simian immunodeficiency virus envelope glycoprotein, gp160.
    Chen B; Zhou G; Kim M; Chishti Y; Hussey RE; Ely B; Skehel JJ; Reinherz EL; Harrison SC; Wiley DC
    J Biol Chem; 2000 Nov; 275(45):34946-53. PubMed ID: 10944528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaca mulatta) against the infection with SIVmac32H grown on T-cells or derived ex vivo.
    Luke W; Coulibaly C; Dittmer U; Voss G; Oesterle R; Makoschey B; Sauermann U; Jurkiewicz E; Stahl-Henning C; Petry H; Hunsmann G
    Virology; 1996 Feb; 216(2):444-50. PubMed ID: 8607276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate.
    Srivastava IK; Stamatatos L; Kan E; Vajdy M; Lian Y; Hilt S; Martin L; Vita C; Zhu P; Roux KH; Vojtech L; C Montefiori D; Donnelly J; Ulmer JB; Barnett SW
    J Virol; 2003 Oct; 77(20):11244-59. PubMed ID: 14512572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypervariable epitope constructs representing variability in envelope glycoprotein of SIV induce a broad humoral immune response in rabbits and rhesus macaques.
    Meyer D; Anderson DE; Gardner MB; Torres JV
    AIDS Res Hum Retroviruses; 1998 Jun; 14(9):751-60. PubMed ID: 9643375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chimeric protein of simian immunodeficiency virus envelope glycoprotein gp140 and Escherichia coli aspartate transcarbamoylase.
    Chen B; Cheng Y; Calder L; Harrison SC; Reinherz EL; Skehel JJ; Wiley DC
    J Virol; 2004 May; 78(9):4508-16. PubMed ID: 15078931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.
    Edinger AL; Ahuja M; Sung T; Baxter KC; Haggarty B; Doms RW; Hoxie JA
    J Virol; 2000 Sep; 74(17):7922-35. PubMed ID: 10933700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simian Immunodeficiency Virus SIVmac239, but Not SIVmac316, Binds and Utilizes Human CD4 More Efficiently than Rhesus CD4.
    Fellinger CH; Gardner MR; Bailey CC; Farzan M
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge.
    Bogers WM; Niphuis H; ten Haaft P; Laman JD; Koornstra W; Heeney JL
    AIDS; 1995 Dec; 9(12):F13-8. PubMed ID: 8605046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of B-cell epitopes in the envelope glycoproteins of simian immunodeficiency virus.
    Benichou S; Venet A; Beyer C; Tiollais P; Madaule P
    Virology; 1993 Jun; 194(2):870-4. PubMed ID: 7684879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques.
    Silvera P; Flanagan B; Kent K; Rud E; Powell C; Corcoran T; Bruck C; Thiriart C; Haigwood NL; Stott EJ
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1295-304. PubMed ID: 7848685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally occurring V1-env region variants mediate simian immunodeficiency virus SIVmac escape from high-titer neutralizing antibodies induced by a protective subunit vaccine.
    Petry H; Pekrun K; Hunsmann G; Jurkiewicz E; Lüke W
    J Virol; 2000 Dec; 74(23):11145-52. PubMed ID: 11070011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.